Larvol Delta - Mateon-Announces-the-Filing-of-an-IND-with-US-FDA-to-Evaluate-its-Antisense-Drug-Candidate-OT101-in-COVID19-patients

trabedersen (OT-101) - Autotelic, Mateon Therapeutics

remdesivir - Generic mfg.

http://www.globenewswire.com/news-release/2020/04/27/2022399/0/en/Mateon-Announces-the-Filing-of-an-IND-with-US-FDA-to-Evaluate-its-Antisense-Drug-Candidate-OT-101-in-COVID-19-patients.html

Apr 27, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next